The startup that wants to cure diseases and slow aging, with the help of AI | Semafor

"I wanted to leave some kind of legacy," Zhavoronkov told Semafor.

Insilico didn't die and ended up being one of the early computational biology startups in a field that is now exploding.

Read at Semafor